Although patients undergoing infliximab treatment showed numerically higher treatment survival rates compared to those on adalimumab, this difference did not reach statistical significance ( Figure 1 ).
← all excerpts
Dashboard-Guided Anti-TNF Induction: An Effective Strategy to Minimize Immunogenicity While Avoiding Immunomodulators-A Single-Center Cohort Study.
1
—
—